484 Results (Page 1 of 20)
UAE Markets Research Reports
UAE Lipid Disorder Therapeutics Market Analysis
The UAE Lipid Disorder Therapeutics Market was valued at $183.7 Mn in 2023 and is predicted to grow at a CAGR of 15.63% from 2023 to 2030, to $507.6 Mn by 2030. UAE Lipid Disorder Therapeutics Market is growing due to the Growing Geriatric Population, Advancements in Therapeutics, Government Initiatives, and Healthcare Investments. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., Julphar, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Cadila Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
UAE Head and Neck Cancer Therapeutics Market Analysis
The UAE Head and Neck Cancer Therapeutics Market was valued at $22.19 Mn in 2023 and is predicted to grow at a CAGR of 15.50% from 2023 to 2030, to $60.84 Mn by 2030. The key drivers of this industry include rising incidence, healthcare spending, and growing healthcare infrastructure. The industry is primarily dominated by players such as Pfizer, Merck, Novartis, and AstraZeneca among others.
UAE Bariatric Surgery Devices Market Analysis
The UAE Bariatric Surgery Devices Marketwas valued at $13.3 Mn in 2023 and is projected to grow at a CAGR of 6.2% from 2023 to 2023, to $20.3 Mn by 2030. The demand for bariatric operations is anticipated due to increasing demand for minimally invasive surgeries, technological advancements, rising awareness about bariatric surgery, rising incidence of adult obesity, increase in sedentary lifestyle, increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, are driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Olympus Corporation, Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
UAE Contact Lenses Market Analysis
UAE Contact Lenses Market was valued at $85.70 Mn in 2023 and is predicted to grow at a CAGR of 9.9% from 2023 to 2030, to $165.95 Mn by 2030. The key drivers of this industry include rising disposable income, high prevalence of myopia, and focus on appearance and active lifestyles. The industry is primarily dominated by Bausch and Lomb, CooperVision, Alcon Vision, and Essilor among others.
UAE Primary Hyperoxaluria (PH) Therapeutics Market Analysis
UAE Primary Hyperoxaluria (PH) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. One of the key factors propelling the growth of the hyperoxaluria drug market is the rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Therapeutics Market are Allena Pharmaceuticals, Inc., Intellia Therapeutics, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
UAE Growth Hormone Deficiency Clinical Trials Market Analysis
This report presents a strategic analysis of the UAE Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy and expert insights.
UAE Exosome Research Market Analysis
The UAE Exosome Research Market was valued at $0.8 Mn in 2023 and is projected to grow at a CAGR of 17% from 2023 to 2023, to $2.5 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as ExoCel Bio,Global Pharma, Modern Pharmaceuticals LLC, Epygen Biotech, Thermo Fisher Scientific, CellSave among others.
UAE Dental Caries Detectors Market Analysis
The UAE Dental Caries Detectors Market was valued at $1.1 Mn in 2023 and is predicted to grow at a CAGR of 9.9% from 2023 to 2030, to $2.2 Mn by 2030. UAE Dental Caries Detectors Market is growing due to Increasing Dental Awareness and Education, High Prevalence of dental caries, and Technological Advancements. The market is primarily dominated by players such as Smile 360, Pacific Dental Services, Dental Services Group, Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, and Planmeca.
UAE Clinical Nutrition for Diabetes Care Market Analysis
The UAE Clinical Nutrition for Diabetes Care Market was valued at $10.75 Mn in 2023 and is predicted to grow at a CAGR of 5.78% from 2023 to 2030, to $15.93 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestlé Health Science, Eli Lily, Baxter International, Boehringer Ingelheim, and among others.
UAE Cardiac Pacemakers Market Analysis
The UAE Cardiac Pacemakers Market was valued at $20.23 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $26.99 Mn by 2030. The key drivers of this industry include the high prevalence of cardiovascular diseases, advancements in technology, and government support. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
UAE Insulin Market Analysis
This report presents a strategic analysis of the UAE Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Insulin Market, offering unmatched value, accuracy and expert insights.
UAE Mental Health Apps Market Analysis
The UAE Mental Health Apps Market was valued at $31 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $88.68 Mn by 2030. The key drivers of this industry include a rising population, increasing smartphone penetration, and a shortage of professionals. The industry is primarily dominated by players such as Calm, Headspace, Moodpath, and Mindshift CBT among others.
UAE Clinical Nutrition for Cancer Care Market Analysis
The UAE Clinical Nutrition for Cancer Care Market was valued at $28.1 Mn in 2023 and is predicted to grow at a CAGR of 6.04% from 2023 to 2030, to $42.4 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, improved healthcare infrastructure, and rising disposable incomes. The prominent players of the UAE Clinical Nutrition for Cancer Care Market are Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, Pfizer, and Fresenius Kabi, among others.
UAE Gram-Negative Infection Therapeutics Market Analysis
The UAE Gram-Negative Infection Therapeutics Market was valued at $74.4 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030 to $118.7 Mn by 2030. This growth is driven by increasing prevalence, with a rate of approximately 9.8% in healthcare settings. Major players in this market include AbbVie Inc. and Bayer AG, among others.
UAE Home Infusion Therapy Market
The UAE Home Infusion Therapy Market was valued at $179.8 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $330.8 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the UAE Home Infusion Therapy Market are Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
UAE Hepatitis A Therapeutics Market Analysis
The UAE Hepatitis A Therapeutics Market was valued at $3.69 Mn in 2023 and is predicted to grow at a CAGR of 3.2% from 2023 to 2030 to $4.6 Mn by 2030. Key industry drivers include insurance coverage, healthcare expenditure and research, improved healthcare infrastructure, globalization and trade, and tourism and travel. Prominent companies in this sector, such as Sanofi, and, Merck Sharp and Dohme Corp., play a significant role.
UAE Constipation Therapeutics Market Analysis
UAE Constipation Therapeutics Market was valued at $91 Mn in 2022 and is estimated to reach $162 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. The constipation therapeutics market is growing driven by the global rise in constipation prevalence associated with aging, sedentary lifestyles, and poor dietary habits, and further fuelled by an expanding elderly population more prone to chronic conditions. Key players in this industry include Abbott, Almirall, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Medtronic, Norgine Pharmaceuticals, Pfizer, Sanofi, and Takeda Pharmaceutical.
UAE Lymphoma Therapeutics Market Analysis
UAE Lymphoma Therapeutics Market was valued at $126.21 Mn in 2023 and is predicted to grow at a CAGR of 11.30 % from 2023 to 2030, to $267.03 Mn by 2030. The key drivers of this industry include escalating lymphoma incidence rate, increasing healthcare expenditure, and growing geriatric population. The industry is primarily dominated by Bristol Myers Squibb Company, F. Hoffmann-La Roche, Novartis AG, Kyowa Kirin, and Merck & Co. among others.
UAE Oncology Drugs Market Analysis
By 2030, it is anticipated that the UAE oncology drugs market will reach a value of $2.540 Bn from $1.243 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in UAE is dominated by a few large pharmaceutical companies such as Biopharma Middle East & Africa, Neopharma Pharmaceutical Plant, and Newbridge Pharmaceuticals FZ LLC. The oncology market in UAE is segmented by different therapeutic areas, into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. The market is also segmented based on treatment types, such as surgery, radiation therapy, chemotherapy, and targeted therapy.
UAE Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the UAE Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.
UAE Over The Counter (OTC) Analgesics Market Analysis
This report presents a strategic analysis of the UAE Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.
UAE Artificial Intelligence (AI) in Healthcare Market Analysis
The UAE Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.04 Bn in 2022 to $0.72 Bn by 2030, registering a CAGR of 46.22% during the forecast period of 2022-2030. The market will be driven by government investment in this area and the growing number of private companies working on AI-powered healthcare solutions. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Healthigo & Mubadala Healthcare.
UAE Artificial Intelligence (AI) in Medical Imaging Market Analysis
UAE artificial intelligence (AI) in medical Imaging market size was valued at $8 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.4% from 2022 to 2030 and will reach $90Mn. The market is segmented by AI technology, solution, modality, application, and end User. The UAE is home to some of the world's leading healthcare providers and technology companies. The country has made significant investments in the development of AI technologies, which has led to the availability of advanced AI-based medical imaging solutions. Some of the key players in this market are CureMetrix UAE, HeartVista, Sophia Genetics, AIDoc Medical, Zebra Medical Vision, GE Healthcare, Siemens Healthineers, Philips Healthcare, Fujifilm Medical Systems, Canon Medical Systems, and others.
UAE Lung Cancer Drugs Market Analysis
The UAE Lung Cancer Drug Market is projected to grow from $48 Mn in 2022 to $97 Mn by 2030, registering a CAGR of 9.3% during the forecast period of 2022 - 2030. According to the World Health Organization (WHO), lung cancer is the second most common cancer in both men and women in the UAE, accounting for 13% of all cancer cases. Some of the major local players in the UAE lung cancer drug market include Emirates Pharmaceutical Industries, Gulf Pharmaceutical Industries, and Julphar.
UAE Digital Health Market Analysis
The UAE Digital Health market is projected to grow from $1.06 Bn in 2022 to $4.42 Bn by 2030, registering a CAGR of 19.6% during the forecast period of 2022 - 2030. Driven by the COVID–19 impact generating space and requirement for digital solutions and adoption of the same by the population at large, the digital health market has exponentially grown in UAE. The market is segmented by solution, by deployment & by end–use. Some of the major players include Altibbi, Okadoc & Vezeeta.